IL-1α blockade delayed lung cancer progression more robustly than IL-1β blockade (Fig. 4G); notably, though, the combination of both exhibited an apparent synergistic effect in reducing tumor growth that was comparable to treating mice with anakinra (Fig. 4G). This evidence concerns the gene IL1A and lung carcinoma.